Back to Medicines and chemicals

Temporary position statement: finfish farm facilities permitted to discharge bronopol

Scope

This temporary regulatory position applies to finfish farm facilities that have an authorisation to discharge residues of medicinal products containing bronopol.

Bronopol is the active ingredient in medicinal products used to treat fungal (Saprolegnia sp) infections.

Currently, operators may only use and discharge a particular named medicinal product containing bronopol. This regulatory position allows operators to use and discharge any product that has an equivalent formulation to the named product.

Regulatory position

Any operator of a finfish farm facility that has an authorisation to discharge a specified medicinal product whose sole active ingredient is bronopol (50 %) may discharge any other medicinal product whose sole active ingredient is also bronopol at 50 % concentration.

SEPA will not treat discharges of such other products as non-compliances when reporting on operator compliance or for enforcement provided that the operator adheres to the conditions relating to the product specified in the permit as if those conditions also applied to the other bronopol-containing product or products discharged under this regulatory position.

About this position

This regulatory position remains subject to review by SEPA at any time. It is SEPA’s intention to incorporate the provisions of this position into all relevant finfish aquaculture sector permits in due course.